1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011. 61:69–90.
2. Hricak H, Gatsonis C, Chi DS, Amendola MA, Brandt K, Schwartz LH, et al. Role of imaging in pretreatment evaluation of early invasive cervical cancer: results of the intergroup study American College of Radiology Imaging Network 6651-Gynecologic Oncology Group 183. J Clin Oncol. 2005. 23:9329–9337.
3. Togashi K, Morikawa K, Kataoka ML, Konishi J. Cervical cancer. J Magn Reson Imaging. 1998. 8:391–397.
4. Liang CC, Tseng CJ, Soong YK. The usefulness of cystoscopy in the staging of cervical cancer. Gynecol Oncol. 2000. 76:200–203.
5. Pecorelli S, Zigliani L, Odicino F. Revised FIGO staging for carcinoma of the cervix. Int J Gynaecol Obstet. 2009. 105:107–108.
6. Hancke K, Heilmann V, Straka P, Kreienberg R, Kurzeder C. Pretreatment staging of cervical cancer: is imaging better than palpation? Role of CT and MRI in preoperative staging of cervical cancer: single institution results for 255 patients. Ann Surg Oncol. 2008. 15:2856–2861.
7. Hawighorst H, Schoenberg SO, Knapstein PG, Knopp MV, Schaeffer U, Essig M, et al. Staging of invasive cervical carcinoma and of pelvic lymph nodes by high resolution MRI with a phased-array coil in comparison with pathological findings. J Comput Assist Tomogr. 1998. 22:75–81.
8. Hricak H, Lacey CG, Sandles LG, Chang YC, Winkler ML, Stern JL. Invasive cervical carcinoma: comparison of MR imaging and surgical findings. Radiology. 1988. 166:623–631.
9. Sheu MH, Chang CY, Wang JH, Yen MS. Cervical carcinoma: assessment of parametrial invasion and lymph node metastasis with magnetic resonance imaging. Zhonghua Yi Xue Za Zhi (Taipei). 2000. 63:634–640.
10. Subak LL, Hricak H, Powell CB, Azizi L, Stern JL. Cervical carcinoma: computed tomography and magnetic resonance imaging for preoperative staging. Obstet Gynecol. 1995. 86:43–50.
11. Hricak H, Yu KK, Powell CB, Subak LL, Stem J, Arenson RL. Comparison of diagnostic studies in the pretreatment evaluation of stage Ib carcinoma of the cervix. Acad Radiol. 1996. 3:Suppl 1. S44–S46.
12. Sharma DN, Thulkar S, Goyal S, Shukla NK, Kumar S, Rath GK, et al. Revisiting the role of computerized tomographic scan and cystoscopy for detecting bladder invasion in the revised FIGO staging system for carcinoma of the uterine cervix. Int J Gynecol Cancer. 2010. 20:368–372.
13. Nam H, Huh SJ, Park W, Bae DS, Kim BG, Lee JH, et al. Prognostic significance of MRI-detected bladder muscle and/or serosal invasion in patients with cervical cancer treated with radiotherapy. Br J Radiol. 2010. 83:868–873.
14. Sundborg MJ, Taylor RR, Mark J, Elg SA. Cystoscopy after computed tomography scan to identify bladder invasion in cervical cancer. Obstet Gynecol. 1998. 92:364–366.
15. Chung H, Ahn HS, Kim YS, Lee EJ, Ryu HS, Chang KH, et al. The value of cystoscopy and intravenous urography after magnetic resonance imaging or computed tomography in the staging of cervical carcinoma. Yonsei Med J. 2001. 42:527–531.
16. Janus CL, Mendelson DS, Moore S, Gendal ES, Dottino P, Brodman M. Staging of cervical carcinoma: accuracy of magnetic resonance imaging and computed tomography. Clin Imaging. 1989. 13:114–116.
17. Massad LS, Calvello C, Gilkey SH, Abu-Rustum NR. Assessing disease extent in women with bulky or clinically evident metastatic cervical cancer: yield of pretreatment studies. Gynecol Oncol. 2000. 76:383–387.